期刊文献+

缬沙坦对原发性高血压患者血管内皮功能及臂踝脉搏波传导速度的影响 被引量:7

Effect of valsartan on vascular endothelial function and brachial-ankle pulse wave velocity in patients with essential hypertension
原文传递
导出
摘要 目的探讨缬沙坦对原发性高血压患者血管内皮功能及臂踝脉搏波传导速度(baPWV)的影响。方法检测30例原发性高血压患者应用缬沙坦治疗前后血压、血一氧化氮(NO)及臂踝脉搏波传导速度的变化。结果应用缬沙坦后,原发性高血压患者血压及臂踝脉搏波传导速度显著下降(P〈0.05及P〈0.01)、NO明显提高(P〈0.01),且臂踝脉搏波传导速度下降与NO升高之间具有相关性(r=-0.71,P〈0、01)。结论缬沙坦除可有效降压外,还有逆转原发性高血压患者血管内皮功能、改善大动脉弹性的作用,同时臂踝脉搏波传导速度可用于评估缬沙坦对血管内皮功能的改善程度。 Objective To investigate the effect of valsartan on vascular endothelial function and brachialankle pulse wave velocity ( baPWV ) in patients with essential hypertension ( EH ). Methods Blood pressure, NO value and brachial-ankle pulse wave velocity were determined and analyzed in 30 patients with essential hypertension before and after therapy of valsartan. Results Both blood pressure and brachial-ankle pulse wave velocity were reduced greatly( P 〈0.05 and P 〈0.01 ) ,while serum NO increased significantly( P 〈0.01 ) following valsartan therapy, and brachial-ankle pulse wave velocity was well correlated to serum NO ( r = -0.71, P 〈 0.01 ). Conclusions Valsartan is not only effective in the control of blood pressure, but also effective in reversing the impaired endothelial function and artery elasticity in patients with essential hypertension, at the same time brachial-ankle pulse wave velocity is also a good surrogate of endothelial functional improvement induced by valsartan therapy.
出处 《中国综合临床》 北大核心 2008年第10期1023-1024,共2页 Clinical Medicine of China
关键词 原发性高血压病 缬沙坦 血管内皮功能 臂踝脉搏波传导速度 Essential hypertension Valsartan Endothelial function Brachial-ankle pulse wave velocity
  • 相关文献

参考文献6

二级参考文献11

  • 1刘国仗.胰岛素抵抗及其检测方法[J].中华心血管病杂志,1996,24(1):3-4. 被引量:125
  • 2Bonora E, Fomentini G, Caleaterra F, et el, HOMA estimatca insulin resistance is an independent predictors of cardiovascular aiseasein type diabetic subjects:pro-spective data from the verona diabetes complications study.Diabetes Care,2002,25:1135-1141.
  • 3Levy D, Garrison RJ, Savage DD, et al. Prognastic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med, 1990,322(22):1561-1566.
  • 4Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol, 1996,78(2) : 197-202.
  • 5陈灏珠,译.心脏病学.5版.北京:人民卫生出版社,2001:741-746.
  • 6Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension:a meta-analysis of randomized double blind studies. JAMA, 1996,275 : 1507-1513.
  • 7Dzau VJ. Tissue, renin-angiotensln, system in myocardial hypertrophy and failure. Arch Intern Med, 1993,153:937.
  • 8Evans FC. Humoral facters deterring the blood pressure response to comverting enzyme inhibition and carcium channel blockade. Am J Hyperten, 1990,3 (5) : 605.
  • 9Weber KT,Brilla CC. Pathological hypertrophy and catdiac interstitium. Circulation, 1991,83 ( 10 ) : 1862.
  • 10朱平,管月帆,丁汉臣.氯沙坦治疗高血压病逆转左室肥厚的疗效观察[J].国外医学(心血管疾病分册),2000,27(6):356-358. 被引量:25

共引文献7

同被引文献78

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部